PapersPMID:23660094
[Amelioration of inflammatory reaction in patients with severe sepsis with inosine].
What moved
1 findingHow to read these marks →- Decreases alanine aminotransferase
very limited
“The lowering of alanine transaminase (ALT), total bilirubin, B-type natriuretic peptide (BNP), oxygenation index was more marked in inosine within 6-hour and after 6-hour groups than those of conventional therapy group (ALT: 42.0 ± 10.8 U/L, 46.0 ± 7.9 U/L vs. 63.0 ± 9.4 U/L, total bilirubin: 16.3 ± 6.7 μmol/L, 18.3 ± 7.3 μmol/L vs. 28.1 ± 8.5 μmol/L, BNP: 322.0 ± 28.7 ng/L, 347.0 ± 31.4 ng/L vs. 428.0 ± 43.2 ng/L, oxygenation index: 210.0 ± 23.8 mm Hg, 198.0 ± 21.4 mm Hg vs. 163.0 ± 15.2 mm Hg, all P<0.05).”
- Study
- RCT
- Dose studied
- inosine 600 mg by intravenous infusion twice daily for 10-14 days or until death or ICU discharge, started within 6 hours or after 6 hours, added to routine treatment
- Population
- Adults with severe sepsis in an intensive care unit, routine treatment in all arms; two inosine arms (started within 6 hours and after 6 hours) against routine treatment alone
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- severe sepsis patients hospitalized in intensive care unit (ICU) from March 2011 to August 2012
- Participants
- 85
- Comparator
- no treatment
- Duration
- not reported
- Endpoints measured
- 11